Skip to main content
Erschienen in: European Surgery 4/2015

01.08.2015 | Original Article

Diagnosis and treatment of benign inflammatory esophageal diseases

verfasst von: I. Kristo, MD, S.F. Schoppmann, MD

Erschienen in: European Surgery | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Summary

Background

Nowadays, benign inflammatory esophageal diseases represent a rising socioeconomic burden. Recently, novel therapeutic approaches have been introduced to enrich personalized surgical options.

Methods

A PubMed research was conducted and merged with institutional guidelines and data.

Results

Magnetic sphincter augmentation strengthens the lower esophageal sphincter and therefore recreates the natural reflux barrier. Electrical sphincter stimulation offers the possibility to personalize minimal invasive treatment and considers even changing lifestyles. Endoscopic antireflux procedures try to mimic the outcome of laparoscopic fundoplication and aim to improve the angle of His. However, laparoscopic fundoplication remains the surgical treatment of choice in advanced reflux disease.
Reflux can also cause eosinophilic infiltration and therefore hinders diagnosis of eosinophilic esophagitis. Once diagnosis is established, dietary modifications and topical steroids offer relevant relief. Reflux produces Barrett’s esophagus, a neoplastic progression, which is commonly treated with radiofrequency ablation.

Conclusion

Novel therapeutic options are facing the rising incidence of benign inflammatory diseases.
Literatur
1.
Zurück zum Zitat El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871–80.PubMedCentralPubMed El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871–80.PubMedCentralPubMed
2.
Zurück zum Zitat Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL. Central adiposity and risk of Barrett’s esophagus. Gastroenterology. 2007;133(2):403–11.PubMed Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL. Central adiposity and risk of Barrett’s esophagus. Gastroenterology. 2007;133(2):403–11.PubMed
3.
Zurück zum Zitat Spechler SJ, Souza RF. Barrett’s esophagus. N Engl J Med. 2014;371(9):836–45.PubMed Spechler SJ, Souza RF. Barrett’s esophagus. N Engl J Med. 2014;371(9):836–45.PubMed
4.
Zurück zum Zitat van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ. Increasing incidence of Barrett’s oesophagus in the general population. Gut. 2005;54(8):1062–6.PubMedCentralPubMed van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ. Increasing incidence of Barrett’s oesophagus in the general population. Gut. 2005;54(8):1062–6.PubMedCentralPubMed
5.
Zurück zum Zitat Oezcelik A, Ayazi S, DeMeester SR, et al. Adenocarcinoma of the esophagus in the young. J Gastrointest Surg. 2013;17(6):1032–5.PubMed Oezcelik A, Ayazi S, DeMeester SR, et al. Adenocarcinoma of the esophagus in the young. J Gastrointest Surg. 2013;17(6):1032–5.PubMed
6.
Zurück zum Zitat Mulder DJ, Justinich CJ. Understanding eosinophilic esophagitis: the cellular and molecular mechanisms of an emerging disease. Mucosal Immunol. 2011;4(2):139–47.PubMed Mulder DJ, Justinich CJ. Understanding eosinophilic esophagitis: the cellular and molecular mechanisms of an emerging disease. Mucosal Immunol. 2011;4(2):139–47.PubMed
7.
Zurück zum Zitat Ma X, Xu Q, Zheng Y, et al. Prevalence of esophageal eosinophilia and eosinophilic esophagitis in adults: a population-based endoscopic study in Shanghai, China. Dig Dis Sci. 2015;60(6):1716–23.PubMed Ma X, Xu Q, Zheng Y, et al. Prevalence of esophageal eosinophilia and eosinophilic esophagitis in adults: a population-based endoscopic study in Shanghai, China. Dig Dis Sci. 2015;60(6):1716–23.PubMed
8.
Zurück zum Zitat Gonsalves N, Yang GY, Doerfler B, Ritz S, Ditto AM, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142(7):1451–9.PubMed Gonsalves N, Yang GY, Doerfler B, Ritz S, Ditto AM, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142(7):1451–9.PubMed
9.
Zurück zum Zitat Moawad FJ, Veerappan GR, Lake JM, et al. Correlation between eosinophilic oesophagitis and aeroallergens. Aliment Pharmacol Ther. 2010;31(4):509–15.PubMed Moawad FJ, Veerappan GR, Lake JM, et al. Correlation between eosinophilic oesophagitis and aeroallergens. Aliment Pharmacol Ther. 2010;31(4):509–15.PubMed
10.
Zurück zum Zitat Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan JE, Goldman H. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology. 1982;83(4):818–23.PubMed Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan JE, Goldman H. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology. 1982;83(4):818–23.PubMed
11.
Zurück zum Zitat Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. Gastroenterology. 2014;147(6):1238–54.PubMed Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. Gastroenterology. 2014;147(6):1238–54.PubMed
12.
Zurück zum Zitat Attwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38(1):109–16.PubMed Attwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38(1):109–16.PubMed
13.
Zurück zum Zitat Philpott H, Nandurkar S, Thien F, Gibson PR, Royce SG. Eosinophilic esophagitis: a clinicopathological review. Pharmacol Ther. 2015;146:12–22.PubMed Philpott H, Nandurkar S, Thien F, Gibson PR, Royce SG. Eosinophilic esophagitis: a clinicopathological review. Pharmacol Ther. 2015;146:12–22.PubMed
14.
Zurück zum Zitat Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335(8683):205–8.PubMed Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335(8683):205–8.PubMed
15.
Zurück zum Zitat Badillo R, Francis D. Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther. 2014;5(3):105–12.PubMedCentralPubMed Badillo R, Francis D. Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther. 2014;5(3):105–12.PubMedCentralPubMed
16.
Zurück zum Zitat Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28.PubMed Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28.PubMed
17.
Zurück zum Zitat Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53(7):1024–31.PubMedCentralPubMed Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53(7):1024–31.PubMedCentralPubMed
18.
Zurück zum Zitat Kwiatek MA, Pandolfino JE, Hirano I, Kahrilas PJ. Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). Gastrointest Endosc. 2010;72(2):272–8.PubMedCentralPubMed Kwiatek MA, Pandolfino JE, Hirano I, Kahrilas PJ. Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). Gastrointest Endosc. 2010;72(2):272–8.PubMedCentralPubMed
19.
Zurück zum Zitat Angelchik JP, Cohen R. A new surgical procedure for the treatment of gastroesophageal reflux and hiatal hernia. Surg Gynecol Obstet. 1979;148(2):246–8.PubMed Angelchik JP, Cohen R. A new surgical procedure for the treatment of gastroesophageal reflux and hiatal hernia. Surg Gynecol Obstet. 1979;148(2):246–8.PubMed
20.
Zurück zum Zitat Samelson SL, Weiser HF, Bombeck CT, et al. A new concept in the surgical treatment of gastroesophageal reflux. Ann Surg. 1983;197(3):254–9.PubMedCentralPubMed Samelson SL, Weiser HF, Bombeck CT, et al. A new concept in the surgical treatment of gastroesophageal reflux. Ann Surg. 1983;197(3):254–9.PubMedCentralPubMed
21.
Zurück zum Zitat Kauten JR, Mansour KA. Complications of the Angelchik prosthesis in the management of gastroesophageal reflux. Am Surg. 1986;52(4):208–13.PubMed Kauten JR, Mansour KA. Complications of the Angelchik prosthesis in the management of gastroesophageal reflux. Am Surg. 1986;52(4):208–13.PubMed
22.
Zurück zum Zitat Bonavina L, Saino G, Lipham JC, Demeester TR. LINX(®) reflux management system in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux. Therap Adv Gastroenterol. 2013;6(4):261–8.PubMedCentralPubMed Bonavina L, Saino G, Lipham JC, Demeester TR. LINX(®) reflux management system in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux. Therap Adv Gastroenterol. 2013;6(4):261–8.PubMedCentralPubMed
23.
Zurück zum Zitat Ganz RA, Gostout CJ, Grudem J, Swanson W, Berg T, DeMeester TR. Use of a magnetic sphincter for the treatment of GERD: a feasibility study. Gastrointest Endosc. 2008;67(2):287–94.PubMed Ganz RA, Gostout CJ, Grudem J, Swanson W, Berg T, DeMeester TR. Use of a magnetic sphincter for the treatment of GERD: a feasibility study. Gastrointest Endosc. 2008;67(2):287–94.PubMed
24.
Zurück zum Zitat Bonavina L, Saino GI, Bona D, et al. Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial. J Gastrointest Surg. 2008;12(12):2133–40.PubMed Bonavina L, Saino GI, Bona D, et al. Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial. J Gastrointest Surg. 2008;12(12):2133–40.PubMed
25.
Zurück zum Zitat Bonavina L, DeMeester T, Fockens P, et al. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial. Ann Surg. 2010;252(5):857–62.PubMed Bonavina L, DeMeester T, Fockens P, et al. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial. Ann Surg. 2010;252(5):857–62.PubMed
26.
Zurück zum Zitat Lipham JC, DeMeester TR, Ganz RA, et al. The LINX(R) reflux management system: confirmed safety and efficacy now at 4 years. Surg Endosc. 2012;26(10):2944–9.PubMed Lipham JC, DeMeester TR, Ganz RA, et al. The LINX(R) reflux management system: confirmed safety and efficacy now at 4 years. Surg Endosc. 2012;26(10):2944–9.PubMed
27.
Zurück zum Zitat Ganz RA, Peters JH, Horgan S, et al. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med. 2013;368(8):719–27.PubMed Ganz RA, Peters JH, Horgan S, et al. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med. 2013;368(8):719–27.PubMed
28.
Zurück zum Zitat Miholic J, Sporn E. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med. 2013;368(21):2038–9.PubMed Miholic J, Sporn E. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med. 2013;368(21):2038–9.PubMed
29.
Zurück zum Zitat Riegler M, Schoppman SF, Bonavina L, Ashton D, Horbach T, Kemen M. Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study. Surg Endosc. 2014;29(5):1123–9.PubMed Riegler M, Schoppman SF, Bonavina L, Ashton D, Horbach T, Kemen M. Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study. Surg Endosc. 2014;29(5):1123–9.PubMed
30.
Zurück zum Zitat Bonavina L, Saino G, Bona D, Sironi A, Lazzari V. One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center. J Am Coll Surg. 2013;217(4):577–85.PubMed Bonavina L, Saino G, Bona D, Sironi A, Lazzari V. One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center. J Am Coll Surg. 2013;217(4):577–85.PubMed
31.
Zurück zum Zitat Schwameis K, Schwameis M, Zorner B, et al. Modern GERD treatment: feasibility of minimally invasive esophageal sphincter augmentation. Anticancer Res. 2014;34(5):2341–8.PubMed Schwameis K, Schwameis M, Zorner B, et al. Modern GERD treatment: feasibility of minimally invasive esophageal sphincter augmentation. Anticancer Res. 2014;34(5):2341–8.PubMed
32.
Zurück zum Zitat Lipham JC, Taiganides PA, Louie BE, Ganz RA, Demeester TR. Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease. Dis Esophagus. 2014;28(4):305–11.PubMed Lipham JC, Taiganides PA, Louie BE, Ganz RA, Demeester TR. Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease. Dis Esophagus. 2014;28(4):305–11.PubMed
33.
Zurück zum Zitat Ellis F, Berne TV, Settevig K. The prevention of experimentally induced reflux by electrical stimulation of the distal esophagus. Am J Surg. 1968;115(4):482–7.PubMed Ellis F, Berne TV, Settevig K. The prevention of experimentally induced reflux by electrical stimulation of the distal esophagus. Am J Surg. 1968;115(4):482–7.PubMed
34.
Zurück zum Zitat Clarke JO, Jagannath SB, Kalloo AN, Long VR, Beitler DM, Kantsevoy SV. An endoscopically implantable device stimulates the lower esophageal sphincter on demand by remote control: a study using a canine model. Endoscopy. 2007;39(1):72–6.PubMed Clarke JO, Jagannath SB, Kalloo AN, Long VR, Beitler DM, Kantsevoy SV. An endoscopically implantable device stimulates the lower esophageal sphincter on demand by remote control: a study using a canine model. Endoscopy. 2007;39(1):72–6.PubMed
35.
Zurück zum Zitat Sanmiguel CP, Hagiike M, Mintchev MP, et al. Effect of electrical stimulation of the LES on LES pressure in a canine model. Am J Physiol Gastrointest Liver Physiol. 2008;295(2):G389–94.PubMed Sanmiguel CP, Hagiike M, Mintchev MP, et al. Effect of electrical stimulation of the LES on LES pressure in a canine model. Am J Physiol Gastrointest Liver Physiol. 2008;295(2):G389–94.PubMed
36.
Zurück zum Zitat Rodriguez L, Rodriguez P, Neto MG, et al. Short-term electrical stimulation of the lower esophageal sphincter increases sphincter pressure in patients with gastroesophageal reflux disease. Neurogastroenterol Motil. 2012;24(5):446–50, e213.PubMed Rodriguez L, Rodriguez P, Neto MG, et al. Short-term electrical stimulation of the lower esophageal sphincter increases sphincter pressure in patients with gastroesophageal reflux disease. Neurogastroenterol Motil. 2012;24(5):446–50, e213.PubMed
37.
Zurück zum Zitat Eypasch E. Electrical stimulation of the lower esophageal sphincter: an emerging therapy for treatment of GORD. Eur Surg. 2014;46(2):57–64. Eypasch E. Electrical stimulation of the lower esophageal sphincter: an emerging therapy for treatment of GORD. Eur Surg. 2014;46(2):57–64.
38.
Zurück zum Zitat Banerjee R, Pratap N, Kalpala R, Reddy DN. Effect of electrical stimulation of the lower esophageal sphincter using endoscopically implanted temporary stimulation leads in patients with reflux disease. Surg Endosc. 2014;28(3):1003–9.PubMed Banerjee R, Pratap N, Kalpala R, Reddy DN. Effect of electrical stimulation of the lower esophageal sphincter using endoscopically implanted temporary stimulation leads in patients with reflux disease. Surg Endosc. 2014;28(3):1003–9.PubMed
39.
Zurück zum Zitat Rodriguez L, Rodriguez P, Gomez B, et al. Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease. Endoscopy. 2013;45(8):595–604.PubMed Rodriguez L, Rodriguez P, Gomez B, et al. Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease. Endoscopy. 2013;45(8):595–604.PubMed
40.
Zurück zum Zitat Siersema P, Smout A, Conchillo J, Booth M, Ruurda J, Wu J. Electric stimulation therapy (EST) of the lower esophageal sphincter (LES): an effective therapy for refractory GERD—interim results of an International multicenter trial. Am J Gastroenterol. 2013;108:S28. Siersema P, Smout A, Conchillo J, Booth M, Ruurda J, Wu J. Electric stimulation therapy (EST) of the lower esophageal sphincter (LES): an effective therapy for refractory GERD—interim results of an International multicenter trial. Am J Gastroenterol. 2013;108:S28.
41.
Zurück zum Zitat Shaheen NJ. The rise and fall (and rise?) of endoscopic anti-reflux procedures. Gastroenterology. 2006;131(3):952–4.PubMed Shaheen NJ. The rise and fall (and rise?) of endoscopic anti-reflux procedures. Gastroenterology. 2006;131(3):952–4.PubMed
42.
Zurück zum Zitat Arts J, Bisschops R, Blondeau K, et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol. 2012;107(2):222–30.PubMed Arts J, Bisschops R, Blondeau K, et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol. 2012;107(2):222–30.PubMed
43.
Zurück zum Zitat Schiefke I, Zabel-Langhennig A, Neumann S, Feisthammel J, Moessner J, Caca K. Long term failure of endoscopic gastroplication (EndoCinch). Gut. 2005;54(6):752–8.PubMedCentralPubMed Schiefke I, Zabel-Langhennig A, Neumann S, Feisthammel J, Moessner J, Caca K. Long term failure of endoscopic gastroplication (EndoCinch). Gut. 2005;54(6):752–8.PubMedCentralPubMed
44.
Zurück zum Zitat Wong RF, Davis TV, Peterson KA. Complications involving the mediastinum after injection of Enteryx for GERD. Gastrointest Endosc. 2005;61(6):753–6.PubMed Wong RF, Davis TV, Peterson KA. Complications involving the mediastinum after injection of Enteryx for GERD. Gastrointest Endosc. 2005;61(6):753–6.PubMed
45.
Zurück zum Zitat Bell RC, Cadiere GB. Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations. Surg Endosc. 2011;25(7):2387–99.PubMedCentralPubMed Bell RC, Cadiere GB. Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations. Surg Endosc. 2011;25(7):2387–99.PubMedCentralPubMed
46.
Zurück zum Zitat Jobe BA, O’Rourke RW, McMahon BP, et al. Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device. Ann Surg. 2008;248(1):69–76.PubMed Jobe BA, O’Rourke RW, McMahon BP, et al. Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device. Ann Surg. 2008;248(1):69–76.PubMed
47.
Zurück zum Zitat Cadiere GB, Rajan A, Germay O, Himpens J. Endoluminal fundoplication by a transoral device for the treatment of GERD: a feasibility study. Surg Endosc. 2008;22(2):333–42.PubMed Cadiere GB, Rajan A, Germay O, Himpens J. Endoluminal fundoplication by a transoral device for the treatment of GERD: a feasibility study. Surg Endosc. 2008;22(2):333–42.PubMed
48.
Zurück zum Zitat Witteman BP, Strijkers R, de Vries E, et al. Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice. Surg Endosc. 2012;26(11):3307–15.PubMedCentralPubMed Witteman BP, Strijkers R, de Vries E, et al. Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice. Surg Endosc. 2012;26(11):3307–15.PubMedCentralPubMed
49.
Zurück zum Zitat Testoni PA, Testoni S, Mazzoleni G, Vailati C, Passaretti S. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study. Surg Endosc. 2014. Epub ahead of print. Testoni PA, Testoni S, Mazzoleni G, Vailati C, Passaretti S. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study. Surg Endosc. 2014. Epub ahead of print.
50.
Zurück zum Zitat Hunter JG, Kahrilas PJ, Bell RC, et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148(2):324–33, e325.PubMed Hunter JG, Kahrilas PJ, Bell RC, et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148(2):324–33, e325.PubMed
51.
Zurück zum Zitat Trad KS, Barnes WE, Simoni G, et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO randomized clinical trial. Surg Innov. 2015;22(1):26–40.PubMedCentralPubMed Trad KS, Barnes WE, Simoni G, et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO randomized clinical trial. Surg Innov. 2015;22(1):26–40.PubMedCentralPubMed
52.
Zurück zum Zitat Zacherl J, Roy-Shapira A, Bonavina L, et al. Endoscopic anterior fundoplication with the medigus ultrasonic surgical endostapler (MUSE) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Surg Endosc. 2015;29(1):220–9.PubMedCentralPubMed Zacherl J, Roy-Shapira A, Bonavina L, et al. Endoscopic anterior fundoplication with the medigus ultrasonic surgical endostapler (MUSE) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Surg Endosc. 2015;29(1):220–9.PubMedCentralPubMed
53.
Zurück zum Zitat Dallemagne B, Weerts J, Markiewicz S, et al. Clinical results of laparoscopic fundoplication at 10 years after surgery. Surg Endosc. 2006;20(1):159–65.PubMed Dallemagne B, Weerts J, Markiewicz S, et al. Clinical results of laparoscopic fundoplication at 10 years after surgery. Surg Endosc. 2006;20(1):159–65.PubMed
54.
Zurück zum Zitat Vakil N, Shaw M, Kirby R. Clinical effectiveness of laparoscopic fundoplication in a U.S. community. Am J Med. 2003;114(1):1–5.PubMed Vakil N, Shaw M, Kirby R. Clinical effectiveness of laparoscopic fundoplication in a U.S. community. Am J Med. 2003;114(1):1–5.PubMed
55.
Zurück zum Zitat Humphries LA, Hernandez JM, Clark W, Luberice K, Ross SB, Rosemurgy AS. Causes of dissatisfaction after laparoscopic fundoplication: the impact of new symptoms, recurrent symptoms, and the patient experience. Surg Endosc. 2013;27(5):1537–45.PubMed Humphries LA, Hernandez JM, Clark W, Luberice K, Ross SB, Rosemurgy AS. Causes of dissatisfaction after laparoscopic fundoplication: the impact of new symptoms, recurrent symptoms, and the patient experience. Surg Endosc. 2013;27(5):1537–45.PubMed
56.
Zurück zum Zitat Dominitz JA, Dire CA, Billingsley KG, Todd-Stenberg JA. Complications and antireflux medication use after antireflux surgery. Clin Gastroenterol Hepatol. 2006;4(3):299–305.PubMed Dominitz JA, Dire CA, Billingsley KG, Todd-Stenberg JA. Complications and antireflux medication use after antireflux surgery. Clin Gastroenterol Hepatol. 2006;4(3):299–305.PubMed
57.
Zurück zum Zitat Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA. 2001;285(18):2331–8.PubMed Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA. 2001;285(18):2331–8.PubMed
58.
Zurück zum Zitat Galmiche JP, Hatlebakk J, Attwood S, et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011;305(19):1969–77.PubMed Galmiche JP, Hatlebakk J, Attwood S, et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011;305(19):1969–77.PubMed
59.
Zurück zum Zitat Wileman SM, McCann S, Grant AM, Krukowski ZH, Bruce J. Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev. 2010;17(3):CD003243. Wileman SM, McCann S, Grant AM, Krukowski ZH, Bruce J. Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev. 2010;17(3):CD003243.
60.
Zurück zum Zitat Rickenbacher N, Kotter T, Kochen MM, Scherer M, Blozik E. Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis. Surg Endosc. 2014;28(1):143–55.PubMed Rickenbacher N, Kotter T, Kochen MM, Scherer M, Blozik E. Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis. Surg Endosc. 2014;28(1):143–55.PubMed
61.
Zurück zum Zitat Hayeck TJ, Kong CY, Spechler SJ, Gazelle GS, Hur C. The prevalence of Barrett’s esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus. 2010;23(6):451–7.PubMedCentralPubMed Hayeck TJ, Kong CY, Spechler SJ, Gazelle GS, Hur C. The prevalence of Barrett’s esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus. 2010;23(6):451–7.PubMedCentralPubMed
62.
Zurück zum Zitat Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365(15):1375–83.PubMed Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365(15):1375–83.PubMed
63.
Zurück zum Zitat Bonavina L. Selected commentary to review on novel concepts of columnar lined esophagus. Eur Surg. 2014;46:96–7. Bonavina L. Selected commentary to review on novel concepts of columnar lined esophagus. Eur Surg. 2014;46:96–7.
64.
Zurück zum Zitat Sharma P, Morales TG, Sampliner RE. Short segment Barrett’s esophagus—the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol. 1998;93(7):1033–6.PubMed Sharma P, Morales TG, Sampliner RE. Short segment Barrett’s esophagus—the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol. 1998;93(7):1033–6.PubMed
65.
Zurück zum Zitat Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C and M criteria. Gastroenterology. 2006;131(5):1392–9.PubMed Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C and M criteria. Gastroenterology. 2006;131(5):1392–9.PubMed
66.
Zurück zum Zitat Levine DS, Blount PL, Rudolph RE, Reid BJ. Safety of a systematic endoscopic biopsy protocol in patients with Barrett’s esophagus. Am J Gastroenterol. 2000;95(5):1152–7.PubMed Levine DS, Blount PL, Rudolph RE, Reid BJ. Safety of a systematic endoscopic biopsy protocol in patients with Barrett’s esophagus. Am J Gastroenterol. 2000;95(5):1152–7.PubMed
67.
Zurück zum Zitat American Gastroenterological Association, Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140(3):1084–91.PubMed American Gastroenterological Association, Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140(3):1084–91.PubMed
68.
Zurück zum Zitat Iezzi R, Pompili M, La Torre MF, et al. Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma. Dig Liver Dis. 2015;47(3):242–8.PubMed Iezzi R, Pompili M, La Torre MF, et al. Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma. Dig Liver Dis. 2015;47(3):242–8.PubMed
69.
Zurück zum Zitat Chang X, Liu T, Zhang F, et al. Radiofrequency ablation versus partial nephrectomy for clinical T renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis. J Endourol. 2015;29(5):518–25.PubMed Chang X, Liu T, Zhang F, et al. Radiofrequency ablation versus partial nephrectomy for clinical T renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis. J Endourol. 2015;29(5):518–25.PubMed
70.
Zurück zum Zitat Rombouts SJ, Vogel JA, van Santvoort HC, et al. Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Br J Surg. 2015;102(3):182–93.PubMed Rombouts SJ, Vogel JA, van Santvoort HC, et al. Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Br J Surg. 2015;102(3):182–93.PubMed
71.
Zurück zum Zitat Kristo I, Asari R, Rieder E, Riegler M, Schoppmann SF. Treatment of Barrett’s esophagus: update on new endoscopic surgical modalities. Minerva Chir. 2015;70(2):107–18.PubMed Kristo I, Asari R, Rieder E, Riegler M, Schoppmann SF. Treatment of Barrett’s esophagus: update on new endoscopic surgical modalities. Minerva Chir. 2015;70(2):107–18.PubMed
72.
Zurück zum Zitat Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009;360(22):2277–88.PubMed Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009;360(22):2277–88.PubMed
73.
Zurück zum Zitat Shaheen NJ, Overholt BF, Sampliner RE, et al. Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology. 2011;141(2):460–8.PubMedCentralPubMed Shaheen NJ, Overholt BF, Sampliner RE, et al. Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology. 2011;141(2):460–8.PubMedCentralPubMed
74.
Zurück zum Zitat Phoa KN, Pouw RE, van Vilsteren FG, et al. Remission of Barrett’s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology. 2013;145(1):96–104.PubMed Phoa KN, Pouw RE, van Vilsteren FG, et al. Remission of Barrett’s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology. 2013;145(1):96–104.PubMed
75.
Zurück zum Zitat Dunbar KB, Spechler SJ. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol. 2012;107(6):850–62;.PubMedCentralPubMed Dunbar KB, Spechler SJ. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol. 2012;107(6):850–62;.PubMedCentralPubMed
76.
Zurück zum Zitat Heitmiller RF. Prophylactic esophagectomy in Barrett esophagus with high-grade dysplasia. Langenbecks Arch Surg. 2003;388(2):83–7.PubMed Heitmiller RF. Prophylactic esophagectomy in Barrett esophagus with high-grade dysplasia. Langenbecks Arch Surg. 2003;388(2):83–7.PubMed
77.
Zurück zum Zitat Phoa KN, van Vilsteren FG, Weusten BL, et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014;311(12):1209–17.PubMed Phoa KN, van Vilsteren FG, Weusten BL, et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014;311(12):1209–17.PubMed
78.
Zurück zum Zitat Riegler FM, Schoppmann SF. Selected commentary to “Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grad dysplasia. A randomized clinical trial”. Eur Surg. 2014;46:133–6. Riegler FM, Schoppmann SF. Selected commentary to “Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grad dysplasia. A randomized clinical trial”. Eur Surg. 2014;46:133–6.
79.
Zurück zum Zitat Hur C, Choi SE, Rubenstein JH, et al. The cost effectiveness of radiofrequency ablation for Barrett’s esophagus. Gastroenterology. 2012;143(3):567–75.PubMedCentralPubMed Hur C, Choi SE, Rubenstein JH, et al. The cost effectiveness of radiofrequency ablation for Barrett’s esophagus. Gastroenterology. 2012;143(3):567–75.PubMedCentralPubMed
80.
Zurück zum Zitat Committee ASoP, Evans JA, Early DS, Fukami N, et al. Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc. 2012;76(6):1087–94. Committee ASoP, Evans JA, Early DS, Fukami N, et al. Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc. 2012;76(6):1087–94.
81.
Zurück zum Zitat Fitzgerald RC, di Pietro M, Ragunath K. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7–42.PubMed Fitzgerald RC, di Pietro M, Ragunath K. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7–42.PubMed
82.
Zurück zum Zitat Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3(12):1198–206.PubMed Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3(12):1198–206.PubMed
83.
Zurück zum Zitat Sgouros SN, Bergele C, Mantides A. Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol. 2006;18(2):211–7.PubMed Sgouros SN, Bergele C, Mantides A. Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol. 2006;18(2):211–7.PubMed
84.
Zurück zum Zitat Desai TK, Stecevic V, Chang CH, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61(7):795–801.PubMed Desai TK, Stecevic V, Chang CH, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61(7):795–801.PubMed
85.
Zurück zum Zitat Leslie C, Mews C, Charles A, Ravikumara M. Celiac disease and eosinophilic esophagitis: a true association. J Pediatr Gastroenterol Nutr. 2010;50(4):397–9.PubMed Leslie C, Mews C, Charles A, Ravikumara M. Celiac disease and eosinophilic esophagitis: a true association. J Pediatr Gastroenterol Nutr. 2010;50(4):397–9.PubMed
86.
Zurück zum Zitat Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA, American College of Gastroenterolgy. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108(5):679–92.PubMed Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA, American College of Gastroenterolgy. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108(5):679–92.PubMed
87.
Zurück zum Zitat Hirano I. Eosinophilic esophagitis and gastroesophageal reflux disease: there and back again. Clin Gastroenterol Hepatol. 2011;9(2):99–101.PubMed Hirano I. Eosinophilic esophagitis and gastroesophageal reflux disease: there and back again. Clin Gastroenterol Hepatol. 2011;9(2):99–101.PubMed
88.
Zurück zum Zitat Ngo P, Furuta GT, Antonioli DA, Fox VL. Eosinophils in the esophagus—peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol. 2006;101(7):1666–70.PubMed Ngo P, Furuta GT, Antonioli DA, Fox VL. Eosinophils in the esophagus—peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol. 2006;101(7):1666–70.PubMed
89.
Zurück zum Zitat Dellon ES, Speck O, Woodward K, et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol. 2013;108(12):1854–60.PubMed Dellon ES, Speck O, Woodward K, et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol. 2013;108(12):1854–60.PubMed
90.
Zurück zum Zitat Saffari H, Peterson KA, Fang JC, Teman C, Gleich GJ, Pease LF 3rd. Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: implications for endoscopic biopsy. J Allergy Clin Immunol. 2012;130(3):798–800.PubMedCentralPubMed Saffari H, Peterson KA, Fang JC, Teman C, Gleich GJ, Pease LF 3rd. Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: implications for endoscopic biopsy. J Allergy Clin Immunol. 2012;130(3):798–800.PubMedCentralPubMed
91.
Zurück zum Zitat Dellon ES. Do you see what I see? Towards standardized reporting of endoscopic findings in eosinophilic esophagitis. Endoscopy. 2014;46(12):1043–5.PubMed Dellon ES. Do you see what I see? Towards standardized reporting of endoscopic findings in eosinophilic esophagitis. Endoscopy. 2014;46(12):1043–5.PubMed
92.
Zurück zum Zitat Schoepfer AM, Safroneeva E, Bussmann C, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013;145(6):1230–6.PubMed Schoepfer AM, Safroneeva E, Bussmann C, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013;145(6):1230–6.PubMed
93.
Zurück zum Zitat Kim HP, Vance RB, Shaheen NJ, Dellon ES. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(9):988–96.PubMedCentralPubMed Kim HP, Vance RB, Shaheen NJ, Dellon ES. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(9):988–96.PubMedCentralPubMed
94.
Zurück zum Zitat Yazaki E, Woodland P, Sifrim D. Uses of esophageal function testing: dysphagia. Gastrointest Endosc Clin N Am. 2014;24(4):643–54.PubMed Yazaki E, Woodland P, Sifrim D. Uses of esophageal function testing: dysphagia. Gastrointest Endosc Clin N Am. 2014;24(4):643–54.PubMed
95.
Zurück zum Zitat Hirano I. Role of advanced diagnostics for eosinophilic esophagitis. Dig Dis. 2014;32(1–2):78–83.PubMed Hirano I. Role of advanced diagnostics for eosinophilic esophagitis. Dig Dis. 2014;32(1–2):78–83.PubMed
96.
Zurück zum Zitat Kwiatek MA, Hirano I, Kahrilas PJ, Rothe J, Luger D, Pandolfino JE. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology. 2011;140(1):82–90.PubMedCentralPubMed Kwiatek MA, Hirano I, Kahrilas PJ, Rothe J, Luger D, Pandolfino JE. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology. 2011;140(1):82–90.PubMedCentralPubMed
97.
Zurück zum Zitat Markowitz JE, Spergel JM, Ruchelli E, Liacouras CA. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol. 2003;98(4):777–82.PubMed Markowitz JE, Spergel JM, Ruchelli E, Liacouras CA. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol. 2003;98(4):777–82.PubMed
98.
Zurück zum Zitat Kagalwalla AF, Sentongo TA, Ritz S, et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4(9):1097–102.PubMed Kagalwalla AF, Sentongo TA, Ritz S, et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4(9):1097–102.PubMed
99.
Zurück zum Zitat Molina-Infante J, Martin-Noguerol E, Alvarado-Arenas M, Porcel-Carreno SL, Jimenez-Timon S, Hernandez-Arbeiza FJ. Selective elimination diet based on skin testing has suboptimal efficacy for adult eosinophilic esophagitis. J Allergy Clin Immunol. 2012;130(5):1200–2.PubMed Molina-Infante J, Martin-Noguerol E, Alvarado-Arenas M, Porcel-Carreno SL, Jimenez-Timon S, Hernandez-Arbeiza FJ. Selective elimination diet based on skin testing has suboptimal efficacy for adult eosinophilic esophagitis. J Allergy Clin Immunol. 2012;130(5):1200–2.PubMed
100.
Zurück zum Zitat Lucendo AJ, Arias A. Treatment of adult eosinophilic esophagitis with diet. Dig Dis. 2014;32(1–2):120–5.PubMed Lucendo AJ, Arias A. Treatment of adult eosinophilic esophagitis with diet. Dig Dis. 2014;32(1–2):120–5.PubMed
101.
Zurück zum Zitat Alexander JA, Jung KW, Arora AS, et al. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012;10(7):742–9.PubMed Alexander JA, Jung KW, Arora AS, et al. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012;10(7):742–9.PubMed
102.
Zurück zum Zitat Straumann A, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139(5):1526–37.PubMed Straumann A, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139(5):1526–37.PubMed
103.
Zurück zum Zitat von Arnim U, Malfertheiner P. Eosinophilic esophagitis—treatment of eosinophilic esophagitis with drugs: corticosteroids. Dig Dis. 2014;32(1–2):126–9. von Arnim U, Malfertheiner P. Eosinophilic esophagitis—treatment of eosinophilic esophagitis with drugs: corticosteroids. Dig Dis. 2014;32(1–2):126–9.
104.
Zurück zum Zitat Dellon ES, Kim HP, Sperry SL, Rybnicek DA, Woosley JT, Shaheen NJ. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointest Endosc. 2014;79(4):577–85.PubMed Dellon ES, Kim HP, Sperry SL, Rybnicek DA, Woosley JT, Shaheen NJ. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointest Endosc. 2014;79(4):577–85.PubMed
105.
Zurück zum Zitat Jacobs JW Jr., Spechler SJ. A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis. Dig Dis Sci. 2010;55(6):1512–5.PubMedCentralPubMed Jacobs JW Jr., Spechler SJ. A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis. Dig Dis Sci. 2010;55(6):1512–5.PubMedCentralPubMed
Metadaten
Titel
Diagnosis and treatment of benign inflammatory esophageal diseases
verfasst von
I. Kristo, MD
S.F. Schoppmann, MD
Publikationsdatum
01.08.2015
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 4/2015
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-015-0329-5

Weitere Artikel der Ausgabe 4/2015

European Surgery 4/2015 Zur Ausgabe